Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281637726> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W4281637726 abstract "Abstract Background Aprepitant has been shown to reduce chemotherapy‐induced nausea and vomiting in children receiving highly emetogenic chemotherapy (HEC). In this study, we assessed the cost‐effectiveness of aprepitant for children receiving HEC in India, United Kingdom, and the United States. Procedure We utilized individual patient‐level outcome data from a pediatric randomized trial, which demonstrated the superiority of an aprepitant‐based anti‐emetic prophylaxis over standard ondansetron and dexamethasone for HEC. Health state for each day of follow‐up was analyzed and quality‐adjusted life years (QALYs) were estimated. The incremental cost‐utility ratio (ICUR), incremental cost‐effectiveness ratio (ICER), and net monetary benefit (NMB) for each country were estimated. Sensitivity analyses by varying cost of aprepitant, hospitalization, and health state utility values by ±25% were conducted. Results Use of the aprepitant‐based regimen resulted in gain of 0.0019 QALY per chemotherapy cycle along with cost savings of $22.25, $1335.52, and $6612.10 for India, United Kingdom, and the United States, respectively. The cost savings per QALY was estimated to be $12,355.84 for India, $734,282.90 for the United Kingdom, and $3,567,564.11 for the United States. The cost savings for 50% gain in the percentage of days without grade 3 vomiting was $124.18 for India, $7451.63 for the United Kingdom, and $36,892.76 for the United States. The NMB for gain in QALY was $33.62, $1418.60, and $6727.01 for India, United Kingdom, and the United States, respectively. The estimates remained cost‐effective across all scenarios of the sensitivity analyses. Conclusion Aprepitant‐based anti‐emetic regimen is cost‐effective for children receiving HEC. It results in overall cost savings and reduced healthcare‐resource utilization." @default.
- W4281637726 created "2022-06-13" @default.
- W4281637726 creator A5000530935 @default.
- W4281637726 creator A5004315286 @default.
- W4281637726 creator A5032010499 @default.
- W4281637726 creator A5058261490 @default.
- W4281637726 creator A5066091432 @default.
- W4281637726 creator A5069876345 @default.
- W4281637726 creator A5073751384 @default.
- W4281637726 date "2022-06-02" @default.
- W4281637726 modified "2023-10-14" @default.
- W4281637726 title "Cost‐effectiveness analysis of aprepitant‐based anti‐emetic regimen for children receiving highly emetogenic chemotherapy: Individual patient data analysis of a randomized trial" @default.
- W4281637726 cites W1514690104 @default.
- W4281637726 cites W1572678410 @default.
- W4281637726 cites W1974362328 @default.
- W4281637726 cites W1974836670 @default.
- W4281637726 cites W1982549839 @default.
- W4281637726 cites W2021110755 @default.
- W4281637726 cites W2049991212 @default.
- W4281637726 cites W2065258017 @default.
- W4281637726 cites W2074318951 @default.
- W4281637726 cites W2088426029 @default.
- W4281637726 cites W2119440126 @default.
- W4281637726 cites W2169820278 @default.
- W4281637726 cites W2299424875 @default.
- W4281637726 cites W2336997367 @default.
- W4281637726 cites W2608956394 @default.
- W4281637726 cites W2620925856 @default.
- W4281637726 cites W2770753485 @default.
- W4281637726 cites W2903442168 @default.
- W4281637726 cites W2942373062 @default.
- W4281637726 cites W3041685519 @default.
- W4281637726 cites W3086024198 @default.
- W4281637726 cites W3195948962 @default.
- W4281637726 cites W3217790098 @default.
- W4281637726 doi "https://doi.org/10.1002/pbc.29795" @default.
- W4281637726 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35652531" @default.
- W4281637726 hasPublicationYear "2022" @default.
- W4281637726 type Work @default.
- W4281637726 citedByCount "1" @default.
- W4281637726 countsByYear W42816377262023 @default.
- W4281637726 crossrefType "journal-article" @default.
- W4281637726 hasAuthorship W4281637726A5000530935 @default.
- W4281637726 hasAuthorship W4281637726A5004315286 @default.
- W4281637726 hasAuthorship W4281637726A5032010499 @default.
- W4281637726 hasAuthorship W4281637726A5058261490 @default.
- W4281637726 hasAuthorship W4281637726A5066091432 @default.
- W4281637726 hasAuthorship W4281637726A5069876345 @default.
- W4281637726 hasAuthorship W4281637726A5073751384 @default.
- W4281637726 hasConcept C126322002 @default.
- W4281637726 hasConcept C2776694085 @default.
- W4281637726 hasConcept C2777170512 @default.
- W4281637726 hasConcept C2779924295 @default.
- W4281637726 hasConcept C2780574406 @default.
- W4281637726 hasConcept C2780580376 @default.
- W4281637726 hasConcept C2780852908 @default.
- W4281637726 hasConcept C2780884295 @default.
- W4281637726 hasConcept C2781413609 @default.
- W4281637726 hasConcept C42219234 @default.
- W4281637726 hasConcept C71924100 @default.
- W4281637726 hasConceptScore W4281637726C126322002 @default.
- W4281637726 hasConceptScore W4281637726C2776694085 @default.
- W4281637726 hasConceptScore W4281637726C2777170512 @default.
- W4281637726 hasConceptScore W4281637726C2779924295 @default.
- W4281637726 hasConceptScore W4281637726C2780574406 @default.
- W4281637726 hasConceptScore W4281637726C2780580376 @default.
- W4281637726 hasConceptScore W4281637726C2780852908 @default.
- W4281637726 hasConceptScore W4281637726C2780884295 @default.
- W4281637726 hasConceptScore W4281637726C2781413609 @default.
- W4281637726 hasConceptScore W4281637726C42219234 @default.
- W4281637726 hasConceptScore W4281637726C71924100 @default.
- W4281637726 hasIssue "10" @default.
- W4281637726 hasLocation W42816377261 @default.
- W4281637726 hasLocation W42816377262 @default.
- W4281637726 hasOpenAccess W4281637726 @default.
- W4281637726 hasPrimaryLocation W42816377261 @default.
- W4281637726 hasRelatedWork W1985217654 @default.
- W4281637726 hasRelatedWork W2087922570 @default.
- W4281637726 hasRelatedWork W2149641543 @default.
- W4281637726 hasRelatedWork W2223097234 @default.
- W4281637726 hasRelatedWork W2240215470 @default.
- W4281637726 hasRelatedWork W2307524438 @default.
- W4281637726 hasRelatedWork W2746999601 @default.
- W4281637726 hasRelatedWork W2953429140 @default.
- W4281637726 hasRelatedWork W3029783972 @default.
- W4281637726 hasRelatedWork W3192511319 @default.
- W4281637726 hasVolume "69" @default.
- W4281637726 isParatext "false" @default.
- W4281637726 isRetracted "false" @default.
- W4281637726 workType "article" @default.